Tell Congress: Stop Big Pharma's Control of the FDA

The Trump administration promised to end the FDA's "cozy" relationship with pharmaceutical companies. 

Instead, they installed a pharmaceutical industry executive in a key FDA position and increased industry payments to the agency. And new investigations reveal expanded industry ties to drug-approval advisory committees and multiple drugs approved this year based on questionable evidence.

We deserve better.

Tell Congress: We demand an agency that works for patients, not pharmaceutical profits.

For decades, the FDA's scientific standards have been eroding. FDA Commissioner Martin Makary vowed to end the problematic relationship with Big Pharma.

We got the opposite.

Sign now to demand Congress enact real FDA reform that puts patient safety over pharmaceutical profits.

Congress has the power to fix this crisis. 

They can eliminate pharmaceutical industry funding of the FDA's drug-approval process, close the revolving door with mandatory cooling-off periods, ban industry executives from holding positions within regulatory agencies, restore rigorous scientific standards for drug approvals, and require full transparency of all financial ties between FDA officials and pharmaceutical companies.

The American people were promised an end to corruption. We deserve a drug regulator that prioritizes safety and effectiveness over pharmaceutical company profits.

In solidarity,

Action Collective